Pharma/ Biotechnology Investments Specialist, Vasuda Capital Management

Dr. Bhavneesh Sharma, MD, MBA

Pharma/ Biotechnology Investments Specialist

Vasuda Capital Management

Equity Bottom-Up

<p>Our next long position is <a href="https://www.smartkarma.com/entities/23721" target="_blank" data-smartkarma-citation="entities:23721:1">Voyager Therapeutics Inc (VYGR US)</a> , a Cambridge, Massachusetts-based emerging biotechnology company that is developing gene therapies for Parkinson's disease (PD) and some other orphan diseases (<a href="http://voyagertherapeutics.com/programs.php" target="_blank">product pipeline</a>). Using its adenovirus vector-based (AAV) gene therapy, the company is targeting about 100,000 PD patients in the US whose motor symptoms are not adequately controlled despite multiple medications. The PD market is about $2.8 billion in size. </p><p>The company is…</p>

Our next long position is Voyager Therapeutics Inc (VYGR US) , a Cambridge, Massachusetts-based emerging biotechnology company that is developing gene therapies for Parkinson's disease (PD) and some other orphan diseases (product pipeline). Using its adenovirus vector-based (AAV) gene therapy, the company is targeting about 100,000 PD patients in the US whose motor symptoms are not adequately controlled despite multiple medications. The PD market is about $2.8 billion in size. The company is…

New Long Position: Gene Therapy for Parkinson's Disease and Upcoming Catalysts

United States

Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sage Therapeutics (SAGE US)

New Long Position: Gene Therapy for Parkinson's Disease and Upcoming Catalysts

Our next long position is Voyager Therapeutics Inc (VYGR US) , a Cambridge, Massachusetts-based emerging biotechnology company that is developing...

Dr. Bhavneesh Sharma, MD, MBA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)